(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 1.72% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Apyx Medical's revenue in 2024 is $52,349,000.On average, 1 Wall Street analysts forecast APYX's revenue for 2024 to be $1,734,274,936, with the lowest APYX revenue forecast at $1,734,274,936, and the highest APYX revenue forecast at $1,734,274,936. On average, 1 Wall Street analysts forecast APYX's revenue for 2025 to be $1,857,260,873, with the lowest APYX revenue forecast at $1,857,260,873, and the highest APYX revenue forecast at $1,857,260,873.
In 2026, APYX is forecast to generate $2,038,448,606 in revenue, with the lowest revenue forecast at $2,038,448,606 and the highest revenue forecast at $2,038,448,606.